{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:09:34Z","timestamp":1784304574143,"version":"3.55.0"},"reference-count":47,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s329494","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:23:03Z","timestamp":1647530583000},"page":"149-161","source":"Crossref","is-referenced-by-count":5,"title":["Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Antoni","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Rivolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Remak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kantecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeha","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Charbonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1086\/605562","volume":"49","author":"Christensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.2105\/AJPH.2011.300181","volume":"101","author":"Suk","year":"2011","journal-title":"Am J Public Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10096-013-1956-z","volume":"33","author":"Seaton","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3111\/13696998.2014.940423","volume":"17","author":"Ostermann","year":"2014","journal-title":"J Med Econ"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0206893","DOI":"10.1371\/journal.pone.0206893","volume":"13","author":"Tun","year":"2018","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/590061","volume":"47","author":"Kollef","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.diagmicrobio.2014.02.013","volume":"79","author":"Lipsky","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/520743","volume":"28","author":"Lipsky","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3111\/13696990802113196","volume":"11","author":"Tarricone","year":"2008","journal-title":"J Med Econ"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/jac\/dkq302","volume":"65","author":"Dryden","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2334-14-296","volume":"14","author":"Suaya","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/JCM.05817-11","volume":"50","author":"Zervos","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijantimicag.2016.04.023","volume":"48","author":"Nathwani","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/2049936117723228","volume":"4","author":"Pulido-Cejudo","year":"2017","journal-title":"Ther Adv Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"E377","DOI":"10.1111\/1469-0691.12235","volume":"19","author":"Garau","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/AAC.05738-11","volume":"56","author":"Friedland","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12879-015-0822-2","volume":"15","author":"Garau","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1086\/526444","volume":"29","author":"Edelsberg","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/655827","volume":"51","author":"Corey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2217\/cer-2015-0024","volume":"5","author":"Karve","year":"2016","journal-title":"J Comp Eff Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40121-014-0044-8","volume":"3","author":"Athanasakis","year":"2014","journal-title":"Infect Dis Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10198-008-0104-7","volume":"10","author":"Schurmann","year":"2009","journal-title":"Eur J Health Econ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11096-005-1638-8","volume":"27","author":"Grau","year":"2005","journal-title":"Pharm World Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jval.2010.12.006","volume":"14","author":"Bounthavong","year":"2011","journal-title":"Value in Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1469-0691.12463","volume":"20","author":"Bassetti","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/497143","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2147\/IDR.S172366","volume":"11","author":"Leong","year":"2018","journal-title":"Infect Drug Resist"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/AAC.01344-12","volume":"57","author":"Talbot","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Rao N, Gibson E, Lawson R, et al. ZinforoTM (ceftaroline fosamil) versus other empiric initial IV antibiotics for complicated skin and soft tissue infections. Paper presented at: ISPOR2016. Washington, D.C; 2016.","DOI":"10.1016\/j.jval.2016.09.355"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jama.2013.241","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12879-015-1261-9","volume":"15","author":"Kauf","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/jcm8060776","volume":"8","author":"Lan","year":"2019","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12879-016-2100-3","volume":"17","author":"McCool","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1186\/s12879-021-06736-x","volume":"21","author":"Vlachaki","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/cid\/ciy165","volume":"67","author":"O\u2019Riordan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"iv67","DOI":"10.1093\/jac\/dkq256","volume":"65","author":"Corrado","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-013-0114-8","volume":"30","author":"Konychev","year":"2013","journal-title":"Drugs Aging"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jac\/dkm033","volume":"59","author":"Martin","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e0188818","DOI":"10.1371\/journal.pone.0188818","volume":"12","author":"Bosmans","year":"2017","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1128\/AAC.00723-13","volume":"57","author":"Mart\u00edn-Pe\u00f1a","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13756-019-0652-x","volume":"8","author":"Kongnakorn","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00134-017-4962-2","volume":"44","author":"Bassetti","year":"2018","journal-title":"Intensive Care Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/657313","volume":"51","author":"File, Jr","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref47","unstructured":"Botplusweb.portalfarma.com. BOT Plus 2. Base de Datos de Medicamentos [Internet]. Available from: https:\/\/botplusweb.portalfarma.com\/botplus.aspx\/. Accessed March 4, 2022."}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=79187","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=79187","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:23:10Z","timestamp":1647530590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/ceftaroline-fosamil-for-the-empiric-treatment-of-hospitalized-adults-w-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":47,"URL":"https:\/\/doi.org\/10.2147\/ceor.s329494","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}